Human IL-11 Protein, His Tag
分子別名(Synonym)
IL-11,Interleukin-11,AGIF,Oprelvekin,IL11
表達(dá)區(qū)間及表達(dá)系統(tǒng)(Source)
Human IL-11 Protein, His Tag (IL1-H5243) is expressed from human 293 cells (HEK293). It contains AA Pro 22 - Leu 199 (Accession # P20809-1).
Predicted N-terminus: His
蛋白結(jié)構(gòu)(Molecular Characterization)

This protein carries a polyhistidine tag at the N-terminus.
The protein has a calculated MW of 21.0 kDa. The protein migrates as 23-29 kDa when calibrated against Star Ribbon Pre-stained Protein Marker under reducing (R) condition (SDS-PAGE) due to glycosylation.
內(nèi)毒素(Endotoxin)
Less than 0.1 EU per μg by the LAL method / rFC method.
無菌(Sterility)
Negative
純度(Purity)
>90% as determined by SDS-PAGE.
制劑(Formulation)
Lyophilized from 0.22 μm filtered solution in Citrate buffer, pH3.0 with trehalose as protectant.
Contact us for customized product form or formulation.
重構(gòu)方法(Reconstitution)
Please see Certificate of Analysis for specific instructions.
For best performance, we strongly recommend you to follow the reconstitution protocol provided in the CoA.
存儲(Storage)
For long term storage, the product should be stored at lyophilized state at -20°C or lower.
Please avoid repeated freeze-thaw cycles.
This product is stable after storage at:
-20°C to -70°C for 12 months in lyophilized state;
-70°C for 3 months under sterile conditions after reconstitution.

背景介紹
白細(xì)胞介素11(IL-11)是一種多效性細(xì)胞因子,可刺激巨核細(xì)胞生成從而增加血小板產(chǎn)量,同時(shí)激活破骨細(xì)胞、抑制上皮細(xì)胞增殖與凋亡,并能抑制巨噬細(xì)胞介質(zhì)釋放。這些功能對介導(dǎo)IL-11的造血調(diào)控、骨代謝及黏膜保護(hù)作用尤為重要。該細(xì)胞因子還具有抗炎活性,已被提議作為克羅恩病和類風(fēng)濕關(guān)節(jié)炎等慢性炎癥性疾病的治療制劑。盡管早期認(rèn)為IL-11僅存在于哺乳動物,后續(xù)研究證實(shí)其在魚類中亦有表達(dá)。雖然魚類與哺乳動物IL-11的基因結(jié)構(gòu)高度相似且關(guān)鍵氨基酸保守,但二者整體氨基酸同源性較低,其功能可能并不完全對等。
關(guān)鍵字: IL-11;IL-11蛋白;IL-11重組蛋白;ACRO;百普賽斯;
百普賽斯集團(tuán)ACROBiosystems Group(股票代碼:301080)是成立于2010年的跨國生物科技公司,是為全球生物醫(yī)藥、健康產(chǎn)業(yè)領(lǐng)域提供關(guān)鍵生物試劑產(chǎn)品及解決方案的行業(yè)平臺型基石企業(yè)。2021年在創(chuàng)業(yè)板上市。百普賽斯集團(tuán)業(yè)務(wù)遍布全球,橫跨亞洲、北美洲、歐洲,在中國、美國、瑞士等12個城市設(shè)有辦公室、研發(fā)中心及生產(chǎn)基地。目前累計(jì)服務(wù)客戶超6000家,與全球Top 20醫(yī)藥企業(yè)均建立了長期、穩(wěn)定的合作伙伴關(guān)系。集團(tuán)旗下?lián)碛衅放艫CROBiosystems百普賽斯、bioSeedin柏思薈、Condense Capital墾拓資本和ACRODiagnostics百斯醫(yī)學(xué)等。